Delivery Order 36F79718D0513-36C24820N0510

This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $14,650.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract award is not associated with a set-aside designation, indicating open...

This federal contract award, with identification number SPE2DB22D3016|SPE2DB25FAJG9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $4,980.95 and a completion date of January 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...

This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,831.84 and a completion date of December 20, 2024. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...

This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Promedtek Inc., a for-profit medical device manufacturer based in Scottsdale, Arizona. The contract, valued at $12,600.00, is for the supply of REPLEXA and REPLEXA+ neuromuscular stimulation and pain management devices under the VA's Medical Equipment and Supplies Multiple Award Schedule contract. The contract has a period of performance through March 17, 2025 and utilizes a firm-fixed-price pricing...

This federal contract award is for the delivery of the prescription medication REXULTI 2 MG TABLET 30S, placed as a delivery order (SPE2DB22FW52J) with the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,985.55 contract was awarded on May 26, 2022 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger $999,999,999...

This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of REXULTI 2 MG TABLET 30S pharmaceuticals, with a potential value of $13,928.74 and a performance period through February 21, 2024. Amerisourcebergen Drug Corp, as a for-profit prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...

This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,255.24 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as the prime contractor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...

The Defense Logistics Agency awarded a $589.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 140 MG/ML REPATHA SURECLICK prefilled syringes. The single day order, placed on August 9, 2023, will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels. This delivery order was issued under the DLA's Pharmaceutical Prime...

This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUV60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.61 delivery order contract is for the provision of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 10, 2025. There was no set-aside designation for this award. Amerisourcebergen...

This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price type and has a ceiling value of $14,605.44 with a completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...